Effect of dexmedetomidine combined with sufentanil for post-caesarean section intravenous analgesia: a randomised, placebo-controlled study.
Eur J Anaesthesiol
; 31(4): 197-203, 2014 Apr.
Article
em En
| MEDLINE
| ID: mdl-24463478
ABSTRACT
BACKGROUND:
Few studies have investigated the use of dexmedetomidine in obstetric anaesthesia.OBJECTIVE:
To evaluate the effect of dexmedetomidine combined with sufentanil for patient-controlled analgesia (PCA) after caesarean section under spinal anaesthesia.DESIGN:
An interventional, randomised, double-blinded, placebo-controlled clinical study.SETTING:
Department of Anaesthesiology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China. PATIENTS One hundred and twenty parturients (American Society of Anesthesiologists class 1 or 2) scheduled for elective caesarean delivery under spinal anaesthesia randomly allocated into three groups (nâ=â40 each).INTERVENTIONS:
Group 1 physiological saline bolus after delivery and sufentanil PCA, Group 2 dexmedetomidine bolus (0.5âµgâkg) after delivery and sufentanil PCA, Group 3 dexmedetomidine bolus (0.5âµgâkg) after delivery and sufentanil with dexmedetomidine PCA (background infusion of 0.045âµgâkgâh with a bolus of 0.07âµgâkg). MAIN OUTCOMEMEASURES:
The total consumption of sufentanil. Pain scores at rest evaluated with a visual analogue scale (VAS) and Ramsay sedation score (RSS) were recorded at the 4, 8 and 24âh after surgery. The patients' pain threshold (PTh) and pain tolerance threshold (PTTh) were measured before surgery and 1âh after initial study drug administration. Satisfaction scores were collected 24âh after surgery.RESULTS:
Sufentanil consumption in group 3 was 43.9â±â19.2âµg, significantly lower than in group 1 (54.5â±â23.9âµg) and group 2 (56.3â±â20.6âµg) (Pâ<â0.05). Compared with group 3, VAS was increased at 4, 8 and 24âh after surgery in groups 1 and 2 (Pâ<â0.05); there was no difference between groups 1 and 2. PTh and PTTh were significantly increased 1âh after drug administration in groups 2 (1.59â±â0.45, 2.57â±â0.46âmA) and 3 (1.74â±â0.37, 2.56â±â0.48âmA) compared with group 1 (1.49â±â0.49, 2.42â±â0.62âmA) (Pâ<â0.05).CONCLUSION:
The combination of sufentanil and dexmedetomidine for PCA after caesarean section can reduce sufentanil consumption and improve parturients' satisfaction compared with sufentanil PCA alone. TRIAL REGISTRATION ChiCTR-TRC-11001442.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Dor Pós-Operatória
/
Cesárea
/
Sufentanil
/
Dexmedetomidina
Tipo de estudo:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
Limite:
Adult
/
Female
/
Humans
/
Pregnancy
Idioma:
En
Ano de publicação:
2014
Tipo de documento:
Article